Dianthus Therapeutics (DNTH) Accumulated Depreciation & Amortization (2017 - 2025)
Historic Accumulated Depreciation & Amortization for Dianthus Therapeutics (DNTH) over the last 7 years, with Q3 2025 value amounting to $277000.0.
- Dianthus Therapeutics' Accumulated Depreciation & Amortization rose 6586.83% to $277000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $277000.0, marking a year-over-year increase of 6586.83%. This contributed to the annual value of $193000.0 for FY2024, which is 9896.91% up from last year.
- Per Dianthus Therapeutics' latest filing, its Accumulated Depreciation & Amortization stood at $277000.0 for Q3 2025, which was up 6586.83% from $250000.0 recorded in Q2 2025.
- In the past 5 years, Dianthus Therapeutics' Accumulated Depreciation & Amortization ranged from a high of $277000.0 in Q3 2025 and a low of $30000.0 during Q4 2022
- For the 4-year period, Dianthus Therapeutics' Accumulated Depreciation & Amortization averaged around $157200.0, with its median value being $154500.0 (2024).
- Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first skyrocketed by 22333.33% in 2023, then skyrocketed by 6586.83% in 2025.
- Quarter analysis of 4 years shows Dianthus Therapeutics' Accumulated Depreciation & Amortization stood at $30000.0 in 2022, then skyrocketed by 223.33% to $97000.0 in 2023, then skyrocketed by 98.97% to $193000.0 in 2024, then soared by 43.52% to $277000.0 in 2025.
- Its last three reported values are $277000.0 in Q3 2025, $250000.0 for Q2 2025, and $220000.0 during Q1 2025.